New Delhi, Aug. 3 -- New Delhi: The Centre has begun the search for a successor to Drugs Controller General of India (DCGI) Rajeev Singh Raghuvanshi, whose tenure has been extended twice since he took charge in February 2023, as the government moves to resolve a lingering succession issue, according to two officials and a document reviewed by Mint.

The Union health ministry has invited applications for the post of Drugs Controller (India) to head the country's top drug regulator Central Drugs Standard Control Organisation (CDSCO). The development assumes significance for India's $60 billion pharmaceutical market, with the DCGI responsible for ensuring the safety, efficacy, and global quality standards of drugs, medical devices, and clini...